Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

The Authors Reply.

Tennankore KK, Kim SJ, Alwayn I, Kiberd BA.

Kidney Int. 2016 Jul;90(1):227. doi: 10.1016/j.kint.2016.03.017. No abstract available.

PMID:
27312454
2.

De Novo Donor Specific Human Leukocyte Antigen Antibody Screening in Kidney Transplant Recipients After the First Year Post Transplantation: A Medical Decision Analysis.

Kiberd BA, Miller A, Martin S, Tennankore KK.

Am J Transplant. 2016 Apr 23. doi: 10.1111/ajt.13838. [Epub ahead of print]

PMID:
27106124
3.

Prolonged warm ischemia time is associated with graft failure and mortality after kidney transplantation.

Tennankore KK, Kim SJ, Alwayn IP, Kiberd BA.

Kidney Int. 2016 Mar;89(3):648-58. doi: 10.1016/j.kint.2015.09.002. Epub 2015 Dec 30.

4.

Incidence, etiology, and significance of acute kidney injury in the early post-kidney transplant period.

Panek R, Tennankore KK, Kiberd BA.

Clin Transplant. 2016 Jan;30(1):66-70. doi: 10.1111/ctr.12660. Epub 2015 Nov 23.

PMID:
26497636
5.

Comorbidity burden at dialysis initiation and mortality: A cohort study.

Gomez AT, Kiberd BA, Royston JP, Alfaadhel T, Soroka SD, Hemmelgarn BR, Tennankore KK.

Can J Kidney Health Dis. 2015 Sep 8;2:34. doi: 10.1186/s40697-015-0068-3. eCollection 2015.

6.

Contraindications to kidney transplantation: uneven grounds?

Kiberd BA, AlBugami MM, Panek R, Tennankore K.

Transplant Res. 2015 Jul 21;4:2. doi: 10.1186/s13737-015-0024-x. eCollection 2015.

7.

Increases in intravenous magnesium use among hospitalized patients: an institution cross-sectional experience.

Kiberd BA, Tennankore KK, Daley CJ.

Can J Kidney Health Dis. 2015 Jun 13;2:24. doi: 10.1186/s40697-015-0056-7. eCollection 2015.

8.

Frailty and mortality in dialysis: evaluation of a clinical frailty scale.

Alfaadhel TA, Soroka SD, Kiberd BA, Landry D, Moorhouse P, Tennankore KK.

Clin J Am Soc Nephrol. 2015 May 7;10(5):832-40. doi: 10.2215/CJN.07760814. Epub 2015 Mar 4.

9.

Eligibility for the kidney transplant wait list: a model for conceptualizing patient risk.

Kiberd BA, Tennankore KK, West K.

Transplant Res. 2014 Jan 8;3(1):2. doi: 10.1186/2047-1440-3-2.

10.

Screening for BK viremia.

AlBugami MM, Kiberd BA.

Transplantation. 2013 Oct 15;96(7):e50. doi: 10.1097/TP.0b013e3182a049e7. No abstract available.

PMID:
24100843
11.

Death, taxes, and now CKD.

Kiberd BA.

Am J Kidney Dis. 2013 Aug;62(2):220-2. doi: 10.1053/j.ajkd.2013.05.002. No abstract available.

PMID:
23883658
12.

The impact of vascular anastomosis time on early kidney transplant outcomes.

Marzouk K, Lawen J, Alwayn I, Kiberd BA.

Transplant Res. 2013 May 15;2(1):8. doi: 10.1186/2047-1440-2-8.

13.

Blood transfusion in deceased donor kidney transplantation.

Marzouk K, Lawen J, Kiberd BA.

Transplant Res. 2013 Apr 5;2(1):4. doi: 10.1186/2047-1440-2-4.

14.

Estimating the long term impact of kidney donation on life expectancy and end stage renal disease.

Kiberd BA.

Transplant Res. 2013 Feb 16;2(1):2. doi: 10.1186/2047-1440-2-2.

15.

Access to kidney transplantation: outcomes of the non-referred.

Albugami MM, Panek R, Soroka S, Tennankore K, Kiberd BA.

Transplant Res. 2012 Dec 10;1(1):22. doi: 10.1186/2047-1440-1-22.

16.

Limits to intensified mycophenolate mofetil dosing in kidney transplantation.

Kiberd BA, Lawen J, Daley C.

Ther Drug Monit. 2012 Dec;34(6):736-8. doi: 10.1097/FTD.0b013e31826d7bfa.

PMID:
23007746
17.

The impact of an "acute dialysis start" on the mortality attributed to the use of central venous catheters: a retrospective cohort study.

Tennankore KK, Soroka SD, Kiberd BA.

BMC Nephrol. 2012 Jul 30;13:72. doi: 10.1186/1471-2369-13-72.

18.

Kidney transplant survival in pediatric and young adults.

Kiberd JA, Acott P, Kiberd BA.

BMC Nephrol. 2011 Oct 7;12:54. doi: 10.1186/1471-2369-12-54.

19.

Macrocytosis may be associated with mortality in chronic hemodialysis patients: a prospective study.

Tennankore KK, Soroka SD, West KA, Kiberd BA.

BMC Nephrol. 2011 May 11;12:19. doi: 10.1186/1471-2369-12-19.

20.

The role of proton pump inhibitors on early mycophenolic acid exposure in kidney transplantation: evidence from the CLEAR study.

Kiberd BA, Wrobel M, Dandavino R, Keown P, Gourishankar S.

Ther Drug Monit. 2011 Feb;33(1):120-3. doi: 10.1097/FTD.0b013e318206a1b1.

PMID:
21192310
Items per page

Supplemental Content

Loading ...
Write to the Help Desk